Differentiating Between Lead-Time Bias and True Survival Benefits When Discussing Racial and Ethnic Disparities in Melanoma

JAMA Dermatol. 2022 Jun 1;158(6):701. doi: 10.1001/jamadermatol.2022.0330.

Authors

Avani M Kolla¹, Marianne Berwick², David Polsky^{1

3}

Affiliations

¹ Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
² Comprehensive Cancer Center, University of New Mexico, Albuquerque.
³ Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.

PMID: 35442387
DOI: 10.1001/jamadermatol.2022.0330

No abstract available

Publication types

Comment

MeSH terms

Ethnicity
Health Status Disparities
Healthcare Disparities
Humans
Melanoma*
Racial Groups*
United States